Shimon Harary, MD
Endocrinology, Diabetes & Metabolism · Memphis, TNNPI 1801030192
Payments from drug & device makers
Across 1,323 payments — averaging $555.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$453K
- Boehringer Ingelheim$136K
- Novo Nordisk$111K
- Xeris Pharmaceuticals, Inc.$18K
- Abbott$8K
- Medtronic$6K
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 780 | $452,935 |
| Boehringer Ingelheim | 212 | $135,869 |
| Novo Nordisk | 121 | $111,355 |
| Xeris Pharmaceuticals, Inc. | 41 | $18,343 |
| Abbott | 18 | $7,838 |
| Medtronic(2 entities) | 28 | $6,191 |
| Amgen(2 entities) | 38 | $510 |
| Sanofi-aventis U.S. LLC | 12 | $193 |
| AbbVie | 13 | $169 |
| Cequr Corporation | 2 | $165 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $131 |
| Merck | 9 | $122 |
| Corcept Therapeutics | 5 | $117 |
| Mannkind Corporation | 5 | $95 |
| Insulet Corporation | 3 | $58 |
| AstraZeneca(2 entities) | 3 | $47 |
| Sequel Med Tech, LLC | 2 | $44 |
| Recordati_rare_diseases_inc. | 2 | $38 |
| Pfizer | 2 | $33 |
| Radius Health, Inc. | 2 | $31 |
| Nevro Corp. | 2 | $30 |
| IBSA Pharma Inc. | 2 | $30 |
| Optos, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $23 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Abiomed | 1 | $21 |
| EUSA Pharma (US) LLC | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| Clarus Therapeutics Inc. | 1 | $6 |
How this compares
$734,576 in reported general payments places this provider in the 90th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Memphis
- Lisa UsdanMemphis$14.3M
- Pedro VelasquezMemphis$2.4M
- Alan CohenMemphis$1.5M
- Aidar GosmanovMemphis$833K
- Samuel Dagogo-JackMemphis$476K
- Ebenezer NyenweMemphis$438K
- Richard ChildressMemphis$212K
- Deirdre JamesMemphis$92K
- Malini GuptaMemphis$91K
- Benjamin BrannickMemphis$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.